Disc Medicine Statistics
Total Valuation
Disc Medicine has a market cap or net worth of $2.12 billion. The enterprise value is $1.51 billion.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Disc Medicine has 34.77 million shares outstanding. The number of shares has increased by 29.27% in one year.
Current Share Class | 34.77M |
Shares Outstanding | 34.77M |
Shares Change (YoY) | +29.27% |
Shares Change (QoQ) | +5.10% |
Owned by Insiders (%) | 1.10% |
Owned by Institutions (%) | 92.10% |
Float | 29.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.33 |
P/TBV Ratio | 3.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 32.11, with a Debt / Equity ratio of 0.05.
Current Ratio | 32.11 |
Quick Ratio | 31.54 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -70.94 |
Financial Efficiency
Return on equity (ROE) is -26.36% and return on invested capital (ROIC) is -18.57%.
Return on Equity (ROE) | -26.36% |
Return on Assets (ROA) | -17.95% |
Return on Invested Capital (ROIC) | -18.57% |
Return on Capital Employed (ROCE) | -26.19% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.73M |
Employee Count | 84 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Disc Medicine has paid $461,000 in taxes.
Income Tax | 461,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.72% in the last 52 weeks. The beta is 2.50, so Disc Medicine's price volatility has been higher than the market average.
Beta (5Y) | 2.50 |
52-Week Price Change | +35.72% |
50-Day Moving Average | 55.53 |
200-Day Moving Average | 54.56 |
Relative Strength Index (RSI) | 61.28 |
Average Volume (20 Days) | 389,689 |
Short Selling Information
The latest short interest is 2.26 million, so 6.50% of the outstanding shares have been sold short.
Short Interest | 2.26M |
Short Previous Month | 2.83M |
Short % of Shares Out | 6.50% |
Short % of Float | 7.77% |
Short Ratio (days to cover) | 6.54 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -168.76M |
Pretax Income | -90.89M |
Net Income | -145.39M |
EBITDA | -168.64M |
EBIT | -168.76M |
Earnings Per Share (EPS) | -$4.53 |
Full Income Statement Balance Sheet
The company has $649.97 million in cash and $30.92 million in debt, giving a net cash position of $619.05 million or $17.81 per share.
Cash & Cash Equivalents | 649.97M |
Total Debt | 30.92M |
Net Cash | 619.05M |
Net Cash Per Share | $17.81 |
Equity (Book Value) | 614.17M |
Book Value Per Share | 17.70 |
Working Capital | 640.99M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$134.23 million and capital expenditures -$1.33 million, giving a free cash flow of -$135.56 million.
Operating Cash Flow | -134.23M |
Capital Expenditures | -1.33M |
Free Cash Flow | -135.56M |
FCF Per Share | -$3.90 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Disc Medicine does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -29.27% |
Shareholder Yield | -29.27% |
Earnings Yield | -6.84% |
FCF Yield | -6.37% |
Dividend Details Analyst Forecast
The average price target for Disc Medicine is $92.08, which is 50.70% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $92.08 |
Price Target Difference | 50.70% |
Analyst Consensus | Strong Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |